Labcorp has added a new high sensitivity antigen test for screening for active COVID-19 disease to its testing offerings. The nasal swab test was developed by DiaSorin.
The test is called Liaison SARS-CoV-2, and it was cleared by the U.S. Food and Drug Administration (FDA) in October of 2020. The test is available through a doctor's order, Labcorp said. Results are available within 24 to 48 hours.